Panbela Therapeutics, Inc. (PBLA)

Panbela Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2	0	2	20	28	24
Market Cap Growth	-50.27%	-99.87%	-92.59%	-26.42%	14.99%	-92.66%
Enterprise Value	6	3	7	8	19	22
PE Ratio	-	0.00	-0.04	-2.00	-5.77	-3.86
PB Ratio	-0.54	0.00	-0.19	1.98	3.26	17.29
P/FCF Ratio	-0.07	0.00	-0.09	-3.02	-7.14	-8.74
P/OCF Ratio	-0.07	0.00	-0.10	-3.02	-7.14	-8.74
EV/EBITDA Ratio	-0.16	-0.05	-0.20	-0.79	-3.59	-4.89
EV/EBIT Ratio	-	-	-	-	-3.52	-3.33
EV/FCF Ratio	-0.23	-0.10	-0.44	-1.25	-4.80	-7.89
Debt / Equity Ratio	-1.32	-1.10	-0.85	0	0	0.08
Debt / EBITDA Ratio	-0.12	-0.10	-0.20	-	-	-0.03
Debt / FCF Ratio	-0.17	-0.21	-0.43	-	-	-0.04
Quick Ratio	0.05	0.22	0.17	4.58	6.85	1.60
Current Ratio	0.17	0.25	0.23	4.62	7.15	1.76
Interest Coverage	-106.76	161.81	-118.38	-910.00	-338.47	-1.97
Return on Equity (ROE)	855.56%	536.37%	434.00%	-99.25%	-56.44%	-447.65%
Return on Assets (ROA)	-258.93%	-214.06%	-701.75%	-78.74%	-48.59%	-197.20%
Return on Capital (ROIC)	-3505.85%	-10597.93%	2829.29%	-98.02%	-68.11%	-287.94%
Earnings Yield	-1650.38%	-1270106.82%	-2325.83%	-50.03%	-17.32%	-25.90%
FCF Yield	-1507.00%	-1269402.96%	-1061.02%	-33.10%	-14.00%	-11.44%
Buyback Yield / Dilution	-23880.32%	87.32%	-75.72%	-51.42%	-35.66%	93.89%
Total Shareholder Return	-23880.32%	87.32%	-75.72%	-51.42%	-35.66%	93.89%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.